Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
Saved in:
| Title: | Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma. |
|---|---|
| Authors: | Lau BC; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.; Pediatric Neuro-Oncology Program, UPMC, Pittsburgh, PA, USA., Ajaero DP; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Hoff BA; Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA., Pearson A; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Sajjakulnukit P; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA., Wadden J; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Adam T; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Ji S; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Green AL; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado Anschutz School of Medicine, Children's Hospital Colorado, Aurora, CO, USA., Nabavizadeh A; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cao Y; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Aryal M; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Upadhyaya S; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Franson A; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA., Galban S; Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA., Venneti S; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA., Federowicz B; xCures, Inc., Oakland, CA, USA., Shapiro MA; xCures, Inc., Oakland, CA, USA., Stuhlmiller TJ; xCures, Inc., Oakland, CA, USA., Lyssiotis C; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA., Galban CJ; Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA., Parmar HA; Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA., Ibrahim M; Department of Radiology, University of Michigan Medical School, Ann Arbor, MI, USA., Koschmann C; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2026 Jul 21. Date of Electronic Publication: 2026 Jul 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
